Literature DB >> 21960553

Human retinal pigment epithelium cells as functional models for the RPE in vivo.

Zsolt Ablonczy1, Mohammad Dahrouj, Peter H Tang, Yueying Liu, Kumar Sambamurti, Alan D Marmorstein, Craig E Crosson.   

Abstract

PURPOSE: The two most commonly used in vitro models of the retinal pigment epithelium (RPE) are fetal human RPE (fhRPE) and ARPE-19 cells; however, studies of their barrier properties have produced contradictory results. To compare their utility as RPE models, their morphologic and functional characteristics were analyzed.
METHODS: Monolayers of both cell types were grown on permeable membrane filters. Barrier function and cellular morphology were assessed by transepithelial resistance (TER) measurements and immunohistochemistry. Protein expression was evaluated by immunoblotting and ELISA assays, and retinoid metabolism characterized by HPLC.
RESULTS: Both cultures developed tight junctions. However, only the fhRPE cells were pigmented, uniform in size and shape, expressed high levels of RPE markers, metabolized all-trans retinal, and developed high TER (>400 Ωcm(2)). The net secretion of pigment-epithelium-derived factor (PEDF) was directed apically in both cultures, but fhRPE cells exhibited secretion rates a thousand-fold greater than in ARPE-19 cells. The net secretion of vascular endothelial growth factor (VEGF) was significantly higher in fhRPE cultures and the direction of this secretion was basolateral; while net secretion was apical in ARPE-19 cells. In fresh media, VEGF-E reduced TER in both cultures; however, in conditioned media fhRPE cells did not respond to VEGF-E administration, but retreatment of the conditioned media with anti-PEDF antibodies allowed fhRPE cells to fully respond to VEGF-E.
CONCLUSIONS: Properties of fhRPE cells align with a functionally normal RPE in vivo, while ARPE-19 cells resemble a pathologic or aged RPE. These results suggest a utility for both cell types in understanding distinct, particular aspects of RPE function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21960553      PMCID: PMC3208409          DOI: 10.1167/iovs.11-8021

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  28 in total

1.  Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.

Authors:  Kyoko Ohno-Matsui; Takeshi Yoshida; Tomoko Uetama; Manabu Mochizuki; Ikuo Morita
Journal:  Biochem Biophys Res Commun       Date:  2003-04-11       Impact factor: 3.575

2.  Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

Authors:  J Spranger; M Osterhoff; M Reimann; M Möhlig; M Ristow; M K Francis; V Cristofalo; H P Hammes; G Smith; M Boulton; A F Pfeiffer
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

Review 3.  Mechanisms of fluid accumulation in retinal edema.

Authors:  M F Marmor
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

Review 4.  Cellular mechanisms of blood-retinal barrier dysfunction in macular edema.

Authors:  S A Vinores; N L Derevjanik; H Ozaki; N Okamoto; P A Campochiaro
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

5.  A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers.

Authors:  J Hu; D Bok
Journal:  Mol Vis       Date:  2001-02-07       Impact factor: 2.367

6.  Expression, purification, and MALDI analysis of RPE65.

Authors:  J Ma ; J Zhang; K L Othersen; G Moiseyev; Z Ablonczy; T M Redmond; Y Chen; R K Crouch
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-06       Impact factor: 4.799

Review 7.  The pathogenesis of edema in diabetic maculopathy.

Authors:  R J Antcliff; J Marshall
Journal:  Semin Ophthalmol       Date:  1999-12       Impact factor: 1.975

8.  Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism.

Authors:  M Elizabeth Hartnett; Alexandra Lappas; Diane Darland; Janet R McColm; Stephanie Lovejoy; Patricia A D'Amore
Journal:  Exp Eye Res       Date:  2003-11       Impact factor: 3.467

9.  Regulation of RPE intercellular junction integrity and function by hepatocyte growth factor.

Authors:  Manlin Jin; Ernesto Barron; Shikun He; Stephen J Ryan; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-08       Impact factor: 4.799

10.  Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions.

Authors:  Shaomin Peng; Ron A Adelman; Lawrence J Rizzolo
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-30       Impact factor: 4.799

View more
  105 in total

1.  Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement.

Authors:  Mausumi Bandyopadhyay; Bärbel Rohrer
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

2.  VEGF and PEDF secretion in ARPE-19 and fhRPE cells.

Authors:  Ram Kannan; Parameswaran G Sreekumar; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-21       Impact factor: 4.799

3.  Differential expression of folate receptor-alpha, sodium-dependent multivitamin transporter, and amino acid transporter (B (0, +)) in human retinoblastoma (Y-79) and retinal pigment epithelial (ARPE-19) cell lines.

Authors:  Jwala Jwala; Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Sai Hanuman Sagar Boddu; Dhananjay Pal; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2012-02-03       Impact factor: 2.671

Review 4.  Plasma membrane protein polarity and trafficking in RPE cells: past, present and future.

Authors:  Guillermo L Lehmann; Ignacio Benedicto; Nancy J Philp; Enrique Rodriguez-Boulan
Journal:  Exp Eye Res       Date:  2014-09       Impact factor: 3.467

5.  Systemic treatment with a 5HT1a agonist induces anti-oxidant protection and preserves the retina from mitochondrial oxidative stress.

Authors:  Manas R Biswal; Chulbul M Ahmed; Cristhian J Ildefonso; Pingyang Han; Hong Li; Hiral Jivanji; Haoyu Mao; Alfred S Lewin
Journal:  Exp Eye Res       Date:  2015-08-25       Impact factor: 3.467

6.  Evaluation of Congo Red Staining in Degenerating Porcine Photoreceptors In Vitro: Protective Effects by Structural and Trophic Support.

Authors:  Camilla Mohlin; Dick Delbro; Anders Kvanta; Kjell Johansson
Journal:  J Histochem Cytochem       Date:  2018-04-06       Impact factor: 2.479

7.  Porous poly(ε-caprolactone) scaffolds for retinal pigment epithelium transplantation.

Authors:  Kevin J McHugh; Sarah L Tao; Magali Saint-Geniez
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-25       Impact factor: 4.799

8.  Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo.

Authors:  Mohammad Dahrouj; Oday Alsarraf; Jake C McMillin; Yueying Liu; Craig E Crosson; Zsolt Ablonczy
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-09       Impact factor: 4.799

9.  Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels.

Authors:  Zsolt Ablonczy; Mohammad Dahrouj; Alexander G Marneros
Journal:  FASEB J       Date:  2014-02-20       Impact factor: 5.191

10.  Stress responses of human retinal pigment epithelial cells to glyoxal.

Authors:  Cora Roehlecke; Monika Valtink; Annika Frenzel; Doris Goetze; Lilla Knels; Henning Morawietz; Richard H W Funk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.